Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kum DB"'
Autor:
Taverniti V; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France., Meiss-Heydmann L; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France., Gadenne C; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France., Vanrusselt H; Aligos Belgium BV, Leuven, Belgium., Kum DB; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Giannone F; Institut Hospitalo-universitaire (IHU). Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Pessaux P; Institut Hospitalo-universitaire (IHU). Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Schuster C; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France., Baumert TF; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France.; Institut Hospitalo-universitaire (IHU). Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Institut Universitaire de France, Paris, France., Debing Y; Aligos Belgium BV, Leuven, Belgium., Verrier ER; University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2024 Jun 10; Vol. 6 (10), pp. 101134. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).
Autor:
Debing Y; Aligos Belgium BV, Leuven, Belgium. Electronic address: ydebing@aligos.com., Vanrusselt H; Aligos Belgium BV, Leuven, Belgium., Degrauwe L; Laboratory of Host Pathogen Interactions, Department of Biosystems, KU Leuven, Leuven, Belgium., Silva de Oliveira DA; Laboratory of Host Pathogen Interactions, Department of Biosystems, KU Leuven, Leuven, Belgium., Kariuki CK; Laboratory of Host Pathogen Interactions, Department of Biosystems, KU Leuven, Leuven, Belgium., Ebwanga EJ; Laboratory of Host Pathogen Interactions, Department of Biosystems, KU Leuven, Leuven, Belgium., Bashir S; Laboratory of Host Pathogen Interactions, Department of Biosystems, KU Leuven, Leuven, Belgium., Merckx W; TRANSfarm, Science, Engineering & Technology Group, KU Leuven, Leuven, Belgium., Thatikonda SK; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Rajwanshi V; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Gohil V; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Hong J; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Kum DB; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Acosta Sanchez A; Novalix, Braine-l'Alleud, Belgium., Chanda S; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Blatt LM; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Jekle A; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Symons JA; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Smith DB; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Raboisson P; Aligos Belgium BV, Leuven, Belgium., Lin TI; Aligos Belgium BV, Leuven, Belgium., Beigelman L; Aligos Therapeutics, Inc., South San Francisco, CA, USA., Paeshuyse J; Laboratory of Host Pathogen Interactions, Department of Biosystems, KU Leuven, Leuven, Belgium. Electronic address: jan.paeshuyse@kuleuven.be.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Apr; Vol. 224, pp. 105835. Date of Electronic Publication: 2024 Feb 23.
Autor:
Vanrusselt H; Aligos Belgium BV , Leuven, Belgium., Kum DB; Aligos Belgium BV , Leuven, Belgium.; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Taverniti V; Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR S1110, Université de Strasbourg , Strasbourg, France., Liu C; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Acosta Sanchez A; Novalix , Leuven, Belgium., Corthout N; VIB Bio-imaging Core , Leuven, Belgium., Munck S; VIB Bio-imaging Core , Leuven, Belgium., Baumert TF; Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR S1110, Université de Strasbourg , Strasbourg, France.; Service d'Hépato-gastroenterologie, Pôle Hépato-digestif, IHU Strasbourg, Strasbourg University Hospitals , Strasbourg, France., Beigelman L; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Blatt LM; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Symons JA; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Deval J; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Raboisson P; Aligos Belgium BV , Leuven, Belgium., Verrier ER; Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR S1110, Université de Strasbourg , Strasbourg, France., Jekle A; Aligos Therapeutics, Inc. , South San Francisco, California, USA., Vendeville S; Aligos Belgium BV , Leuven, Belgium., Debing Y; Aligos Belgium BV , Leuven, Belgium.
Publikováno v:
Journal of virology [J Virol] 2023 Oct 31; Vol. 97 (10), pp. e0072223. Date of Electronic Publication: 2023 Sep 27.
Autor:
Kum DB; Aligos Belgium BV, Leuven, Belgium.; Aligos Therapeutics Inc., South San Francisco, California, USA., Vanrusselt H; Aligos Belgium BV, Leuven, Belgium., Acosta Sanchez A; Novalix, Leuven, Belgium., Taverniti V; Strasbourg University, Inserm, Institute for Research on Viral and Hepatic Diseases, UMR S1110, Strasbourg, France., Verrier ER; Strasbourg University, Inserm, Institute for Research on Viral and Hepatic Diseases, UMR S1110, Strasbourg, France., Baumert TF; Strasbourg University, Inserm, Institute for Research on Viral and Hepatic Diseases, UMR S1110, Strasbourg, France.; Hepato-digestive Division, IHU Strasbourg, Strasbourg University Hospitals, Strasbourg, France., Liu C; Aligos Therapeutics Inc., South San Francisco, California, USA., Deval J; Aligos Therapeutics Inc., South San Francisco, California, USA., Corthout N; VIB Bio-imaging Core, Leuven, Belgium., Munck S; VIB Bio-imaging Core, Leuven, Belgium., Beigelman L; Aligos Therapeutics Inc., South San Francisco, California, USA., Blatt LM; Aligos Therapeutics Inc., South San Francisco, California, USA., Symons JA; Aligos Therapeutics Inc., South San Francisco, California, USA., Raboisson P; Aligos Belgium BV, Leuven, Belgium., Jekle A; Aligos Therapeutics Inc., South San Francisco, California, USA., Vendeville S; Aligos Belgium BV, Leuven, Belgium., Debing Y; Aligos Belgium BV, Leuven, Belgium.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2023 Oct 01; Vol. 78 (4), pp. 1252-1265. Date of Electronic Publication: 2023 Apr 28.
Autor:
Rasulova M; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium., Vercruysse T; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium., Paulissen J; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium., Coun C; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium., Suin V; Sciensano, Viral Diseases Service, Scientific Directorate of Infectious Diseases in Humans, Brussels, Belgium., Heyndrickx L; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerpgrid.11505.30, Antwerp, Belgium., Ma J; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Geerts K; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Timmermans J; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium., Mishra N; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Li LH; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Kum DB; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Coelmont L; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Van Gucht S; Sciensano, Viral Diseases Service, Scientific Directorate of Infectious Diseases in Humans, Brussels, Belgium., Karimzadeh H; Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Unit Clinical Pharmacology (EKliP), Helmholtz Center for Environmental Health, Munich, Germany., Thorn-Seshold J; Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Unit Clinical Pharmacology (EKliP), Helmholtz Center for Environmental Health, Munich, Germany., Rothenfußer S; Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.; Unit Clinical Pharmacology (EKliP), Helmholtz Center for Environmental Health, Munich, Germany., Ariën KK; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerpgrid.11505.30, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium., Neyts J; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Dallmeier K; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Thibaut HJ; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Virology and Chemotherapy, Molecular Vaccinology & Vaccine Discovery, Leuven, Belgium.; KU Leuvengrid.5596.f Department of Microbiology, Immunology and Transplantation, Rega Institute, Translational Platform Virology and Chemotherapy (TPVC), Leuven, Belgium.
Publikováno v:
Microbiology spectrum [Microbiol Spectr] 2022 Jun 29; Vol. 10 (3), pp. e0254821. Date of Electronic Publication: 2022 Jun 07.
Autor:
Taverniti V; Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France., Ligat G; Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France., Debing Y; Aligos Belgium BV, 3001 Leuven, Belgium., Kum DB; Aligos Belgium BV, 3001 Leuven, Belgium., Baumert TF; Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France.; Institut Hospitalo-Universitaire, Pôle Hépato-Digestif, Nouvel Hôpital Civil, 67000 Strasbourg, France., Verrier ER; Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, 67000 Strasbourg, France.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 Mar 01; Vol. 11 (5). Date of Electronic Publication: 2022 Mar 01.
Autor:
Kum DB; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Boudewijns R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Ma J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Mishra N; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Schols D; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Dallmeier K; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2020 Mar 02; Vol. 9 (1), pp. 520-533. Date of Electronic Publication: 2020 Mar 02 (Print Publication: 2020).
Autor:
Kum DB; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.; Aligos Belgium, Leuven, Belgium., Mishra N; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Vrancken B; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgium., Thibaut HJ; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Wilder-Smith A; Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany., Lemey P; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgium., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Dallmeier K; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2019; Vol. 8 (1), pp. 1734-1746.
Autor:
Kum DB; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Mishra N; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Boudewijns R; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Gladwyn-Ng I; 2GIGA-Neurosciences, Interdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège, C.H.U. Sart Tilman, Liège, Belgium., Alfano C; 2GIGA-Neurosciences, Interdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège, C.H.U. Sart Tilman, Liège, Belgium., Ma J; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Schmid MA; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Marques RE; 3Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, Brazil., Schols D; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Kaptein S; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Nguyen L; 2GIGA-Neurosciences, Interdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège, C.H.U. Sart Tilman, Liège, Belgium., Neyts J; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Dallmeier K; KU Leuven Department of Microbiology and Immunology, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2018 Dec 13; Vol. 3, pp. 56. Date of Electronic Publication: 2018 Dec 13 (Print Publication: 2018).
Autor:
Xie X; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: xuxie@utmb.edu., Kum DB; KU Leuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Laboratory of Virology and Chemoth, University of Leuven, Leuven, Belgium., Xia H; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Luo H; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA., Shan C; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Zou J; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Muruato AE; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA., Medeiros DBA; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, Ananindeua, Pará State, Brazil., Nunes BTD; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, Ananindeua, Pará State, Brazil., Dallmeier K; KU Leuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Laboratory of Virology and Chemoth, University of Leuven, Leuven, Belgium., Rossi SL; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology and Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA., Weaver SC; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, TX, USA; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology and Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Neyts J; KU Leuven, Rega Institute for Medical Research, Department of Microbiology and Immunology, Laboratory of Virology and Chemoth, University of Leuven, Leuven, Belgium., Wang T; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology and Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Vasconcelos PFC; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, Ananindeua, Pará State, Brazil; Department of Pathology, Pará State University, Belém, Brazil., Shi PY; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: peshi@utmb.edu.
Publikováno v:
Cell host & microbe [Cell Host Microbe] 2018 Oct 10; Vol. 24 (4), pp. 487-499.e5.